Compare ESPR & LIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESPR | LIND |
|---|---|---|
| Founded | 2008 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.7M | 899.2M |
| IPO Year | 2013 | 2011 |
| Metric | ESPR | LIND |
|---|---|---|
| Price | $2.65 | $18.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $7.60 | ★ $22.25 |
| AVG Volume (30 Days) | ★ 4.6M | 755.6K |
| Earning Date | 03-10-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.71 | 5.97 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $403,135,000.00 | N/A |
| Revenue This Year | $0.69 | $10.55 |
| Revenue Next Year | $10.67 | $6.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 21.31 | N/A |
| 52 Week Low | $0.73 | $7.45 |
| 52 Week High | $4.18 | $21.23 |
| Indicator | ESPR | LIND |
|---|---|---|
| Relative Strength Index (RSI) | 40.23 | 51.36 |
| Support Level | $2.37 | $11.27 |
| Resistance Level | $3.02 | $21.23 |
| Average True Range (ATR) | 0.20 | 0.82 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 38.52 | 64.09 |
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
Lindblad Expeditions Holdings Inc provides expedition cruising and adventure travel services. The company operates in two segments: Lindblad and Land Experiences, of which Lindblad generates the vast majority of its revenue. It offers itineraries that feature up-close encounters with wildlife, nature, history, and culture, as well as promote guest empowerment and interactivity. It operates expeditions on intimately-scaled ships and interaction between guests, crew, and the teams of scientists, naturalists, researchers, and photographers that participate in the expeditions. Lindblad operates a fleet of twelve owned expedition ships and five seasonal charter vessels under the Lindblad brand.